Verification of effects on psychological condition by test-food intake in a single dose - Verification of effects on psychological condition by test-food intake in a single dose

CPCC Company Limited0 sites24 target enrollmentApril 12, 2024

Overview

Phase: N/A
Intervention: Not specified
Conditions: Not specified
Sponsor: CPCC Company Limited
Enrollment: 24
Status: Not Yet Recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

April 12, 2024

End Date

June 1, 2023

Last Updated

last year

Study Type

Interventional

Sex

All

Investigators

Sponsor

CPCC Company Limited

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\) Subjects being under some kind of continuous medical treatment, including the test period. (2\) Subjects who have periodically used health\-specific / functional (e.g., gamma\-aminobutyric acid, L. gasseri CP2305\)/ health foods including supplements, which might affect the autonomic nervous system, metabolism and sleep. (3\) Subjects with excessive alcohol intake (not less than 60 g/day/week). (4\) Subjects with extremely irregular eating habits, and subjects having an irregular life rhythm with irregular shift work or midnight one. (5\) Subjects who are under other clinical tests with some kind of medicine/food, or participated in those within four weeks before this trial, or are planning to join those after the consent. (6\) Subjects who are under a large stress condition with some kind of life event, such as house\-moving, transfer, bereavement, etc., within three months before the agreement for this trial and during the test period. (7\) Subjects with any difficulty in giving up drinking since the day before the scheduled date of this trial. (8\) Subjects with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs. (9\) Subjects getting excessive exercise every day. (10\) Subjects with a serious symptom of premenstrual syndrome. (11\) Pregnant, possibly pregnant, and lactating women. (12\) Subjects having some kind of drug and/or food allergy. (13\) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.